Robert Cascella
Director
Mr. Cascella is a corporate director with more than 30 years of experience in the healthcare industry in a range of senior management positions. He most recently served as Special Advisor and Strategic Business Development Leader at Royal Philips, a public
Dutch multinational healthcare company, during 2021. From 2015 to 2021, he served as Executive Vice President of Royal Philips and Chief Executive Officer of Philips’ Diagnosis and Treatment businesses, including businesses serving Radiology, Cardiology
and Oncology, as well as Enterprise Diagnostic Informatics. Mr. Cascella has also served on Philips’ Executive Committee from 2016 to 2021. Since 2021, he has served on the board of directors of Metabolon Inc., a private company using metabolomics
to assist in the discovery of biomarkers. Prior to Philips, Mr. Cascella spent ten years as President and later CEO of Hologic Inc., a public medical device and diagnostic company. He also served on Hologic, Inc.’s board of directors from 2008 to
2013. He has also held senior leadership positions at CFG Capital, NeoVision Corporation and Fisher Imaging Corporation. He currently sits on the Boards of Koru Medical Systems Inc. (since 2022) and Mirion Technologies (since 2021), and is Chair of
the Board of Directors of Neuronetics, Inc. (since 2021).
Mr. Cascella holds a Bachelor’s degree in Accounting from Fairfield University.
He sits on the Audit Committee, Human Resources and Compensation Committee (Chair), and Nominating and Corporate Governance Committee.